BeiGene Reports Lucrative Q1 Amid SEC Audit

BeiGene Reports Lucrative Q1 Amid SEC Audit

Source: 
BioSpace
News Tags: 
snippet: 

BeiGene reported its Q1 2022 results on Thursday. The company report included total product revenue of $261 million, a 146% increase from its 2021 reporting.